Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs

被引：27

作者：

Bolten, WW ^{[1
]}

机构：

[1] Klaus Miehlke Klin, D-65191 Wiesbaden, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷 / 01期

关键词：

D O I：

10.1136/ard.2005.036269

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Treatment of pain in rheumatoid arthritis must take into account the gastrointestinal and cardiovascular risk of individual patients. Adequate results are not yet available, and until they are, treatment recommendations must take into account, not only the more favourable gastrointestinal risk profile of selective COX-2 inhibitors, but also the potential atherothrombotic risk of any NSAID or selective COX-2 inhibitor treatment.

引用

页码：7 / 13

页数：7

共 44 条

[1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[2] A randomized trial of aspirin to prevent colorectal adenomas [J].

Baron, JA ;

Cole, BF ;

Sandler, RS ;

Haile, RW ;

Ahnen, D ;

Bresalier, R ;

McKeown-Eyssen, G ;

Summers, RW ;

Rothstein, R ;

Burke, CA ;

Snover, DC ;

Church, TR ;

Allen, JI ;

Beach, M ;

Beck, GJ ;

Bond, JH ;

Byers, T ;

Greenberg, ER ;

Mandel, JS ;

Marcon, N ;

Mott, LA ;

Pearson, L ;

Saibil, F ;

van Stolk, RU .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) :891-899

[3] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[4] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].

Bresalier, RS ;

Sandler, RS ;

Quan, H ;

Bolognese, JA ;

Oxenius, B ;

Horgan, K ;

Lines, C ;

Riddell, R ;

Morton, D ;

Lanas, A ;

Konstam, MA ;

Baron, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102

[5] Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects [J].

Capone, ML ;

Tacconelli, S ;

Sciulli, MG ;

Grana, M ;

Ricciotti, E ;

Minuz, P ;

Di Gregorio, P ;

Merciaro, G ;

Patrono, C ;

Patrignani, P .

CIRCULATION, 2004, 109 (12) :1468-1471

[6] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. [J].

Catella-Lawson, F ;

Reilly, MP ;

Kapoor, SC ;

Cucchiara, AJ ;

DeMarco, S ;

Tournier, B ;

Vyas, SN ;

FitzGerald, GA .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) :1809-1817

[7] Selective COX-2 inhibition improves endothelial function in coronary artery disease [J].

Chenevard, R ;

Hürlimann, D ;

Béchir, M ;

Enseleit, F ;

Spieker, L ;

Hermann, M ;

Riesen, W ;

Gay, S ;

Gay, RE ;

Neidhart, M ;

Michel, B ;

Lüscher, TF ;

Noll, G ;

Ruschitzka, F .

CIRCULATION, 2003, 107 (03) :405-409

[8] Role of prostacyclin in the cardiovascular response to thromboxane A2 [J].

Cheng, Y ;

Austin, SC ;

Rocca, B ;

Koller, BH ;

Coffman, TM ;

Grosser, T ;

Lawson, JA ;

FitzGerald, GA .

SCIENCE, 2002, 296 (5567) :539-541

[9] COX-2-derived prostacyclin confers atheroprotection on female mice [J].

Egan, KM ;

Lawson, JA ;

Fries, S ;

Koller, B ;

Rader, DJ ;

Smyth, EM ;

FitzGerald, GA .

SCIENCE, 2004, 306 (5703) :1954-1957

[10]

*EMEA, 2004, EMEA2058312004

← 1 2 3 4 5 →